Review



membrane potential assay kit  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Beyotime membrane potential assay kit
    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL <t>assay</t> was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial <t>membrane</t> <t>potential</t> (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Membrane Potential Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 806 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/Enhanced+mitochondrial+membrane+potential+assay+kit+with+JC-1/pmc13091346-69-18-25
    Average 99 stars, based on 806 article reviews
    membrane potential assay kit - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development"

    Article Title: PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development

    Journal: Genes & Diseases

    doi: 10.1016/j.gendis.2025.101947

    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL assay was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial membrane potential (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Figure Legend Snippet: PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL assay was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial membrane potential (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.

    Techniques Used: Expressing, CCK-8 Assay, Software, Flow Cytometry, TUNEL Assay, Staining, Fluorescence, Microscopy, Membrane, Standard Deviation

    Related Articles

    Membrane:

    Article Title: Ultrasmall Prussian blue–integrated cryogel for enhanced ROS scavenging and immunomodulation via cGAS–STING inhibition in wound healing
    Article Snippet: 2,7-Dichlorofluorescin diacetate (DCFH-DA) was acquired from MedChem Express (Monmouth et al., USA). .. The Catalase Assay Kit and Mitochondrial Membrane Potential Assay Kit (JC-1) were from Beyotime Biotechnology Inc. (Shanghai, China). .. The SOD assay kit was from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).

    Article Title: Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis.
    Article Snippet: Osteoarthritis (OA) is a frequently occurring degenerative joint condition involving progressive loss of cartilage integrity accompanied by prolonged inflammatory activity within the joint.. Current therapies mainly alleviate symptoms without halting disease progression.. This study was designed to assess the pharmacological efficacy of bergapten (BeG), a naturally derived furanocoumarin, in osteoarthritis and to clarify its molecular mechanisms of action.

    Article Title: Plasmodium PI3K suppresses the externalization of phosphatidylserine on infected erythrocytes
    Article Snippet: .. To identify the intracellular parasites, the samples were counterstained with Hoechst 33342 (Beyotime, China, Cat# C1027), while the mitochondrial membrane potential was evaluated using the Enhanced Mitochondrial Membrane Potential Assay Kit with JC-1 (Beyotime, China, Cat# C2003S). ..

    Article Title: Photo-downregulation of SIRT4 mitigates aging in mice by enhancing H3K9ac via fatty acid metabolism
    Article Snippet: .. After red light treatment of PAM212 cells, changes in the mitochondrial membrane potential in keratinocytes were detected using the Enhanced Mitochondrial Membrane Potential Assay Kit (C2003S, Beyotime Biotechnology, China). ..

    Article Title: Interleukin-1 Receptor-Associated Kinase 3 Attenuates Chondrocyte Senescence and Osteoarthritis via Inhibition of the TLR7/9–NF-κB Axis
    Article Snippet: .. The ATDC5 cell line was acquired from Ningbo Mingzhou Biotechnology Co., Ltd. A mitochondrial membrane potential assay kit was obtained from Beyotime Biotechnology (Shanghai). .. DCFH-DA, Mito-SOX, and Mito-Tracker were purchased from Dojindo Molecular Technologies in Japan.

    Article Title: Swainsonine Induces Granulosa Cell Apoptosis and Steroidogenic Impairment Associated with Oxidative Stress and Mitochondrial Dysfunction
    Article Snippet: Swainsonine (SW), the principal toxic alkaloid of locoweeds, causes significant reproductive failure in grazing livestock, but its direct cellular targets and mechanisms remain poorly defined.. This study aimed to elucidate the cytotoxic effects of SW on goat ovarian granulosa cells (GCs) and the underlying molecular pathways.. Based on an initial cytotoxicity profile (24h IC50 = 21.79 μM), GCs were treated with 20 μM SW for 24 h to investigate mechanistic endpoints.

    Concentration Assay:

    Article Title: Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis.
    Article Snippet: Osteoarthritis (OA) is a frequently occurring degenerative joint condition involving progressive loss of cartilage integrity accompanied by prolonged inflammatory activity within the joint.. Current therapies mainly alleviate symptoms without halting disease progression.. This study was designed to assess the pharmacological efficacy of bergapten (BeG), a naturally derived furanocoumarin, in osteoarthritis and to clarify its molecular mechanisms of action.

    Incubation:

    Article Title: Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis.
    Article Snippet: Osteoarthritis (OA) is a frequently occurring degenerative joint condition involving progressive loss of cartilage integrity accompanied by prolonged inflammatory activity within the joint.. Current therapies mainly alleviate symptoms without halting disease progression.. This study was designed to assess the pharmacological efficacy of bergapten (BeG), a naturally derived furanocoumarin, in osteoarthritis and to clarify its molecular mechanisms of action.

    Fluorescence:

    Article Title: Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis.
    Article Snippet: Osteoarthritis (OA) is a frequently occurring degenerative joint condition involving progressive loss of cartilage integrity accompanied by prolonged inflammatory activity within the joint.. Current therapies mainly alleviate symptoms without halting disease progression.. This study was designed to assess the pharmacological efficacy of bergapten (BeG), a naturally derived furanocoumarin, in osteoarthritis and to clarify its molecular mechanisms of action.

    other:

    Article Title: Pre-adaptation of stem cell-derived islet organoids to hypoxia via zinc transportation inhibition drives angiogenesis.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER STZ Yeasen Cat#60256ES60 Palmitic acid Sigma-Aldrich Cat#P0500 DMSO Sigma-Aldrich Cat#D8418 SU6656 Selleck Cat#S7774 Tween80 Beyotime Cat#ST2789 ZnPTO Sigma-Aldrich Cat#H6377 Ascorbic acid Sigma-Aldrich Cat#A4544 Chir99021 Selleck Cat#S1263 BMP4 R&D Systems Cat#314-BP-01M bFGF R&D Systems Cat#233-FB-010/CF Activin A R&D Systems Cat#338-AC-01M/CF FGF-10 R&D Systems Cat#345-FG-025 Wnt3a Novoprotein Cat#C22R SANT1 Selleck Cat#S7092 Retinoic acid Sigma-Aldrich Cat#R2625 NOGGIN Novoprotein Cat#CB89 Alk5i-II Selleck Cat#S7223 LDN193189 Sigma-Aldrich Cat#SML0559 hEGF Novoprotein Cat#C029 T3 (Triiodothyronine) Selleck Cat#S5726 Trolox Selleck Cat#S3665 Bemcentinib (R428) Selleck Cat#S2841 γ-secretase inhibitor XX EMD Millipore Cat#565789 MCDB131 Sigma-Aldrich Cat#M8537 DMEM Gibco Cat#10313039 RPMI 1640 Gibco Cat#22400105 Fetal bovine serum (FBS) PAN Seratech Cat#ST30-3302 Y-27632 MedChemExpress Cat#HY-10071 TrypLE Gibco Cat#12604013 Matrigel Corning Cat#354277 Donkey serum Jackson ImmunoResearch Cat#017-000-121 L-Glutamine Gibco Cat#25030081 Bovine serum albumin (BSA) Proliant Cat#69100 Dorsomorphin (DS) MedChemExpress Cat#866405-64-3 Lificiguat (YC-1) Selleck Cat#S7958 Linoleic acid Sigma-Aldrich Cat#L1376 Stearic Acid Sigma-Aldrich Cat#S4751 Critical commercial assays HiScript II 1st Strand cDNA Synthesis Kit Vazyme Cat#R212 SuperReal SYBR Green Kit TIANGEN Cat#FP205 Enhanced BCA Protein Assay Kit Beyotime Cat#P0010 Human proinsulin ELISA kit Mercodia Cat#1118-1-10 Human ultrasensitive C-peptide ELISA kit Mercodia Cat#0111-1-10 Human insulin ELISAkit ALPCO Cat#80-INSHUU-E10 Ultrasensitive insulin ELISA ALPCO Cat#80-INSHUU-E01.1 KAPA Express Extract Kits KAPA Biosystems Cat#KK7101 Annexin V-YSFluorTM 647/PI Apoptosis Detection Kit Yeasen Cat#40304ES60 TRNzol Universal TIANGEN Cat#DP424 Mitochondrial membrane potential assay kit with JC-1 Beyotime Cat#C2005 (Continued on next page) e2 Cell Stem Cell 33, 676–694.e1–e10, April 2, 2026

    Article Title: ROS-responsive EGCG-Fe-Cur nanosystems for radioprotection through antioxidant and inhibition of ferroptosis pathways.
    Article Snippet: Subsequently, the cells were washed twice with PBS and detected by a C6 flow cytometer (BD, Franklin Lakes, NJ, USA).



    Similar Products

    98
    MedChemExpress jc-1 mitochondrial membrane potential assay kit
    Jc 1 Mitochondrial Membrane Potential Assay Kit, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1+Mitochondrial+Membrane+Potential+Assay+Kit/custom%40hy-k0601%4042456829
    Average 98 stars, based on 1 article reviews
    jc-1 mitochondrial membrane potential assay kit - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    98
    MedChemExpress jc 1 assay kit
    MCU regulates mitophagy and mitochondrial function. A. GSEA analysis showed that MCU-associated genes were significantly enriched in the “autophagy of mitochondrion” and “positive regulation of autophagy of mitochondrion” pathways; B. Western blot analysis was performed to detect the expression of mitophagy-related proteins, including PINK1, PRKN, and LC3B, in H1975 and PC9 cells; C, D. Immunofluorescence analysis was used to examine the colocalization of mitochondria and LC3B in H1975 and PC9 cells; E, <t>F.</t> <t>JC-1</t> staining combined with flow cytometry was performed to assess changes in mitochondrial membrane potential in H1975 and PC9 cells; G, H. Flow cytometry was used to detect intracellular ROS levels in H1975 and PC9 cells. Data are presented as the mean ± SD. Statistical analysis was performed using two-sided t-tests. **P < 0.01; ***P < 0.001; ****P < 0.0001.
    Jc 1 Assay Kit, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1+Mitochondrial+Membrane+Potential+Assay+Kit/pmc13468261-115-0-3
    Average 98 stars, based on 1 article reviews
    jc 1 assay kit - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    99
    Beyotime membrane potential assay kit
    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL <t>assay</t> was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial <t>membrane</t> <t>potential</t> (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Membrane Potential Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/Enhanced+mitochondrial+membrane+potential+assay+kit+with+JC-1/pmc13091346-69-18-25
    Average 99 stars, based on 1 article reviews
    membrane potential assay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    98
    MedChemExpress nigericin
    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL <t>assay</t> was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial <t>membrane</t> <t>potential</t> (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Nigericin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1+Mitochondrial+Membrane+Potential+Assay+Kit/pm42364560-54-2-11
    Average 98 stars, based on 1 article reviews
    nigericin - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    98
    MedChemExpress mitochondrial membrane potential
    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL <t>assay</t> was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial <t>membrane</t> <t>potential</t> (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Mitochondrial Membrane Potential, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1+Mitochondrial+Membrane+Potential+Assay+Kit/pm42281376-121-0-8
    Average 98 stars, based on 1 article reviews
    mitochondrial membrane potential - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    98
    MedChemExpress fluorescent probe
    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL <t>assay</t> was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial <t>membrane</t> <t>potential</t> (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
    Fluorescent Probe, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1+Mitochondrial+Membrane+Potential+Assay+Kit/pm42235794-167-2-4
    Average 98 stars, based on 1 article reviews
    fluorescent probe - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    99
    Beyotime tmre mitochondrial membrane potential assay kit
    MSC-mt mitigate oxidative damage and improve <t>mitochondrial</t> function in H 2 O 2 -treated skin fibroblasts. (A–B) Representative flow cytometry plots and quantification of Annexin V/PI staining for apoptosis after H 2 O 2 stimulation, showing that MSC-mt significantly reduce fibroblast apoptosis, whereas rotenone-pretreated mitochondria (mt(R)) exhibit markedly attenuated protective effects. (C–D) Representative plots and quantification of mitoSOX staining for mitochondrial ROS after 180 min H 2 O 2 exposure, showing that MSC-mt suppress mitochondrial ROS accumulation, an effect largely lost following rotenone pretreatment. (E–F) Representative plots and quantification of <t>TMRE</t> staining for mitochondrial membrane potential (ΔΨm) after 180 min H 2 O 2 treatment, showing preservation of mitochondrial membrane potential by MSC-mt but not by mt(R). (G–H) Representative plots and quantification of SA-β-gal staining for cellular senescence after 180 min H 2 O 2 treatment, showing reduced senescence burden in MSC-mt–treated cells, with diminished efficacy observed in the mt(R) group. (I) Representative images and quantification of colony formation assays on day 8 post-treatment, indicating improved long-term proliferative capacity following MSC-mt treatment, an effect substantially weakened following rotenone pretreatment. (J) Heatmap of differentially expressed genes identified by a wound healing PCR array following 180 min of H 2 O 2 stimulation, showing that MSC-mt partially reverse H 2 O 2 -induced transcriptional alterations associated with stress response and repair pathways, an effect attenuated when using mt(R). (K) Representative images of mouse apoptosis protein array analysis after 180 min of H 2 O 2 treatment, showing that MSC-mt partially restore the expression of key anti-apoptotic and pro-survival signaling proteins suppressed by oxidative stress, including phosphorylated AKT (Ser473), BAD (Ser112), ERK (T202), and IκBα (S32), with reduced restoration observed in the mt(R) group. (L) Western blot analysis of phosphorylated AKT at Ser473 expression after 180 min of H 2 O 2 exposure, showing restoration of pro-survival signaling by MSC-mt, which is attenuated in the mt(R) group. All experiments were independently repeated three times (n = 3). Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, not significant.
    Tmre Mitochondrial Membrane Potential Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/Mitochondrial+Membrane+Potential+Assay+Kit+with+TMRE/pmc13049664-84-12-18
    Average 99 stars, based on 1 article reviews
    tmre mitochondrial membrane potential assay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime mitochondrial membrane potential assay kit
    Schematic representation of the synthesis process and therapeutic properties of Cryogel@USPB applied in wounds. (A) Fabrication process of Cryogel@USPB. (B) Cryogel@USPB promotes acute/chronic wounds through regulating macrophage polarization and restraining <t>mitochondrial</t> dysfunction via the cGAS-STING pathway.
    Mitochondrial Membrane Potential Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitochondrial+membrane+potential+assay+kit/JC-1/pmc13062569-51-5-13
    Average 99 stars, based on 1 article reviews
    mitochondrial membrane potential assay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    MCU regulates mitophagy and mitochondrial function. A. GSEA analysis showed that MCU-associated genes were significantly enriched in the “autophagy of mitochondrion” and “positive regulation of autophagy of mitochondrion” pathways; B. Western blot analysis was performed to detect the expression of mitophagy-related proteins, including PINK1, PRKN, and LC3B, in H1975 and PC9 cells; C, D. Immunofluorescence analysis was used to examine the colocalization of mitochondria and LC3B in H1975 and PC9 cells; E, F. JC-1 staining combined with flow cytometry was performed to assess changes in mitochondrial membrane potential in H1975 and PC9 cells; G, H. Flow cytometry was used to detect intracellular ROS levels in H1975 and PC9 cells. Data are presented as the mean ± SD. Statistical analysis was performed using two-sided t-tests. **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Journal: American Journal of Cancer Research

    Article Title: Mitochondrial calcium uniporter as a biomarker in lung adenocarcinoma: regulation of the immune microenvironment, apoptosis, cell cycle and mitophagy

    doi: 10.62347/PGQK3358

    Figure Lengend Snippet: MCU regulates mitophagy and mitochondrial function. A. GSEA analysis showed that MCU-associated genes were significantly enriched in the “autophagy of mitochondrion” and “positive regulation of autophagy of mitochondrion” pathways; B. Western blot analysis was performed to detect the expression of mitophagy-related proteins, including PINK1, PRKN, and LC3B, in H1975 and PC9 cells; C, D. Immunofluorescence analysis was used to examine the colocalization of mitochondria and LC3B in H1975 and PC9 cells; E, F. JC-1 staining combined with flow cytometry was performed to assess changes in mitochondrial membrane potential in H1975 and PC9 cells; G, H. Flow cytometry was used to detect intracellular ROS levels in H1975 and PC9 cells. Data are presented as the mean ± SD. Statistical analysis was performed using two-sided t-tests. **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Article Snippet: JC-1 assay kit (MedChemExpress, New Jersey, USA) is to be used for the mitochondrial membrane potential experiment.

    Techniques: Western Blot, Expressing, Immunofluorescence, Staining, Flow Cytometry, Membrane

    PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL assay was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial membrane potential (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.

    Journal: Genes & Diseases

    Article Title: PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development

    doi: 10.1016/j.gendis.2025.101947

    Figure Lengend Snippet: PDK1 inhibitor JX06 and gefitinib synergistically induced cell apoptosis in gefitinib-resistant lung cancer cells. (A) The protein expression levels of PDK were reduced upon the treatment of PDK1 inhibitor JX06 in PC-9 and PC-9/G cells. (B) B2B and PC-9/G cells were treated with different concentrations of JX06 for 48 h. The cell viabilities were determined by CCK-8. (C – E) The synergy effect between JX06 and gefitinib was determined and analyzed with CompuSyn software. (F) The apoptosis rates were analyzed with flow cytometry after the combined treatment of gefitinib and JX06. (G) The TUNEL assay was performed with the indicated treatment in PC-9/G cells. (H) The cells treated as described were stained with the JC-1 probe and detected using a fluorescence microscope. Red fluorescence indicates the aggregation form of JC-1, showing increased mitochondrial membrane potential (ΔΨm). Green fluorescence indicates the monomeric form of JC-1, which indicates reduced mitochondrial membrane potential (ΔΨm). Data were statistically analyzed with Student’s t -test, and values were shown as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.

    Article Snippet: After different treatments for 48 h, the mitochondrial membrane potential of cells was detected with the enhanced mitochondrial membrane potential assay kit using JC-1 probe (Beyotime, Jiangsu, China), and the fluorescence was analyzed with a fluorescence microscope.

    Techniques: Expressing, CCK-8 Assay, Software, Flow Cytometry, TUNEL Assay, Staining, Fluorescence, Microscopy, Membrane, Standard Deviation

    MSC-mt mitigate oxidative damage and improve mitochondrial function in H 2 O 2 -treated skin fibroblasts. (A–B) Representative flow cytometry plots and quantification of Annexin V/PI staining for apoptosis after H 2 O 2 stimulation, showing that MSC-mt significantly reduce fibroblast apoptosis, whereas rotenone-pretreated mitochondria (mt(R)) exhibit markedly attenuated protective effects. (C–D) Representative plots and quantification of mitoSOX staining for mitochondrial ROS after 180 min H 2 O 2 exposure, showing that MSC-mt suppress mitochondrial ROS accumulation, an effect largely lost following rotenone pretreatment. (E–F) Representative plots and quantification of TMRE staining for mitochondrial membrane potential (ΔΨm) after 180 min H 2 O 2 treatment, showing preservation of mitochondrial membrane potential by MSC-mt but not by mt(R). (G–H) Representative plots and quantification of SA-β-gal staining for cellular senescence after 180 min H 2 O 2 treatment, showing reduced senescence burden in MSC-mt–treated cells, with diminished efficacy observed in the mt(R) group. (I) Representative images and quantification of colony formation assays on day 8 post-treatment, indicating improved long-term proliferative capacity following MSC-mt treatment, an effect substantially weakened following rotenone pretreatment. (J) Heatmap of differentially expressed genes identified by a wound healing PCR array following 180 min of H 2 O 2 stimulation, showing that MSC-mt partially reverse H 2 O 2 -induced transcriptional alterations associated with stress response and repair pathways, an effect attenuated when using mt(R). (K) Representative images of mouse apoptosis protein array analysis after 180 min of H 2 O 2 treatment, showing that MSC-mt partially restore the expression of key anti-apoptotic and pro-survival signaling proteins suppressed by oxidative stress, including phosphorylated AKT (Ser473), BAD (Ser112), ERK (T202), and IκBα (S32), with reduced restoration observed in the mt(R) group. (L) Western blot analysis of phosphorylated AKT at Ser473 expression after 180 min of H 2 O 2 exposure, showing restoration of pro-survival signaling by MSC-mt, which is attenuated in the mt(R) group. All experiments were independently repeated three times (n = 3). Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, not significant.

    Journal: Materials Today Bio

    Article Title: Extracellular biogenic nanoscale mitochondria reprogram the wound microenvironment via ROS scavenging independent of cellular uptake

    doi: 10.1016/j.mtbio.2026.103023

    Figure Lengend Snippet: MSC-mt mitigate oxidative damage and improve mitochondrial function in H 2 O 2 -treated skin fibroblasts. (A–B) Representative flow cytometry plots and quantification of Annexin V/PI staining for apoptosis after H 2 O 2 stimulation, showing that MSC-mt significantly reduce fibroblast apoptosis, whereas rotenone-pretreated mitochondria (mt(R)) exhibit markedly attenuated protective effects. (C–D) Representative plots and quantification of mitoSOX staining for mitochondrial ROS after 180 min H 2 O 2 exposure, showing that MSC-mt suppress mitochondrial ROS accumulation, an effect largely lost following rotenone pretreatment. (E–F) Representative plots and quantification of TMRE staining for mitochondrial membrane potential (ΔΨm) after 180 min H 2 O 2 treatment, showing preservation of mitochondrial membrane potential by MSC-mt but not by mt(R). (G–H) Representative plots and quantification of SA-β-gal staining for cellular senescence after 180 min H 2 O 2 treatment, showing reduced senescence burden in MSC-mt–treated cells, with diminished efficacy observed in the mt(R) group. (I) Representative images and quantification of colony formation assays on day 8 post-treatment, indicating improved long-term proliferative capacity following MSC-mt treatment, an effect substantially weakened following rotenone pretreatment. (J) Heatmap of differentially expressed genes identified by a wound healing PCR array following 180 min of H 2 O 2 stimulation, showing that MSC-mt partially reverse H 2 O 2 -induced transcriptional alterations associated with stress response and repair pathways, an effect attenuated when using mt(R). (K) Representative images of mouse apoptosis protein array analysis after 180 min of H 2 O 2 treatment, showing that MSC-mt partially restore the expression of key anti-apoptotic and pro-survival signaling proteins suppressed by oxidative stress, including phosphorylated AKT (Ser473), BAD (Ser112), ERK (T202), and IκBα (S32), with reduced restoration observed in the mt(R) group. (L) Western blot analysis of phosphorylated AKT at Ser473 expression after 180 min of H 2 O 2 exposure, showing restoration of pro-survival signaling by MSC-mt, which is attenuated in the mt(R) group. All experiments were independently repeated three times (n = 3). Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, not significant.

    Article Snippet: The mitochondrial membrane potential (ΔΨm) of isolated MSC-mt was assessed using a TMRE Mitochondrial Membrane Potential Assay Kit (Beyotime, Cat# C2001S).

    Techniques: Flow Cytometry, Staining, Membrane, Preserving, Protein Array, Expressing, Western Blot

    Schematic representation of the synthesis process and therapeutic properties of Cryogel@USPB applied in wounds. (A) Fabrication process of Cryogel@USPB. (B) Cryogel@USPB promotes acute/chronic wounds through regulating macrophage polarization and restraining mitochondrial dysfunction via the cGAS-STING pathway.

    Journal: Materials Today Bio

    Article Title: Ultrasmall Prussian blue–integrated cryogel for enhanced ROS scavenging and immunomodulation via cGAS–STING inhibition in wound healing

    doi: 10.1016/j.mtbio.2026.103056

    Figure Lengend Snippet: Schematic representation of the synthesis process and therapeutic properties of Cryogel@USPB applied in wounds. (A) Fabrication process of Cryogel@USPB. (B) Cryogel@USPB promotes acute/chronic wounds through regulating macrophage polarization and restraining mitochondrial dysfunction via the cGAS-STING pathway.

    Article Snippet: The Catalase Assay Kit and Mitochondrial Membrane Potential Assay Kit (JC-1) were from Beyotime Biotechnology Inc. (Shanghai, China).

    Techniques:

    The biocompatibility and antioxidant capability assessment of Cryogel@USPB. (A) Cell viability of NIH 3T3 and Raw264.7 cells after co-incubation with Cryogel@USPB at various concentrations (n = 3). (B) Representative fluorescent staining images of live (green)/dead (red) cells of Raw264.7 cells following co-incubation with Cryogel@USPB. (C) Determination of H 2 O 2 depletion capability of Cryogel@USPB (n = 3). (D) SOD-like activity and (E) POD-like activity of Cryogel@USPB (n = 3). (F) ·OH depletion capability and (G) •O 2 − depletion activity using EPR. (H) Representative fluorescent staining images of intracellular ROS in Raw264.7 cells following the treatment of H 2 O 2 and Cryogel@USPB. (I) TEM images of the mitochondria in RAW264.7 cells. (J) Fluorescent images of mitochondrial membrane potential in cells following different treatments. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Ultrasmall Prussian blue–integrated cryogel for enhanced ROS scavenging and immunomodulation via cGAS–STING inhibition in wound healing

    doi: 10.1016/j.mtbio.2026.103056

    Figure Lengend Snippet: The biocompatibility and antioxidant capability assessment of Cryogel@USPB. (A) Cell viability of NIH 3T3 and Raw264.7 cells after co-incubation with Cryogel@USPB at various concentrations (n = 3). (B) Representative fluorescent staining images of live (green)/dead (red) cells of Raw264.7 cells following co-incubation with Cryogel@USPB. (C) Determination of H 2 O 2 depletion capability of Cryogel@USPB (n = 3). (D) SOD-like activity and (E) POD-like activity of Cryogel@USPB (n = 3). (F) ·OH depletion capability and (G) •O 2 − depletion activity using EPR. (H) Representative fluorescent staining images of intracellular ROS in Raw264.7 cells following the treatment of H 2 O 2 and Cryogel@USPB. (I) TEM images of the mitochondria in RAW264.7 cells. (J) Fluorescent images of mitochondrial membrane potential in cells following different treatments. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: The Catalase Assay Kit and Mitochondrial Membrane Potential Assay Kit (JC-1) were from Beyotime Biotechnology Inc. (Shanghai, China).

    Techniques: Incubation, Staining, Activity Assay, Membrane